TWiV 934: Clinical update with Dr. Daniel Griffin

Published: Sept. 10, 2022, 4 a.m.

b'

In his weekly clinical update Dr. Griffin discusses variant influenza virus infections: recommendations for identification, treatment, and prevention for summer and fall 2022,\\xa0low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals, using the right tools at the right time for SARS-COV-2 infection,\\xa0onset and window of SARS-COV-2 infectiousness and temporal correlation with symptom onset,\\xa0transmission of SARS-COV-2: a review of viral, host, and environmental factors,\\xa0antibody persistence and safety through 6 months after heterologous orally aerosolized Ad5-nCoV in individuals primed with two-dose vaccine,\\xa0timely administration of tocilizumab improves outcome of hospitalized COVID-19 patients,\\xa0administration of anti\\u2013SARS-COV-2 monoclonal antibodies after US Food and Drug Administration deauthorization, and\\xa0clinical and genetic risk factors for acute incident venous thromboembolism in ambulatory patients with COVID-19.

Subscribe (free):\\xa0Apple Podcasts,\\xa0Google Podcasts,\\xa0RSS,\\xa0email

Become a\\xa0patron\\xa0of\\xa0TWiV!

Intro music is by\\xa0Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

'